Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-06

Clinical Trial Update: A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for topical jaktinib hydrochloride cream in alopecia areata in Phase 1/2; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jaktinib hydrochloride cream (jaktinib hydrochloride)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Alopecia Areata(AA) | Phase 1, Phase 2 | Status: UNKNOWN